Advertisement

Topics

Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress

12:36 EDT 8 May 2018 | Investing News Network

Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today corporate and financial results for the first quarter of 2018 and recent business progress. As quoted in the press release: “We are encouraged by the initial launch of LUXTURNA™ (voretigene neparvovec-rzyl). We are pleased that three … Continued

The post Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress appeared first on Investing News Network.

Original Article: Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress

NEXT ARTICLE

More From BioPortfolio on "Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...